Login
Aphria NYSE: APHA
Aphria Inc. produces and sells medical cannabis in Canada and internationall
| Name | Aphria |
| Ticker | APHA |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Producer |
| Price | 4.68 |
| 52W Low/High | 2.13 / 6.16 |
| Market cap | 1.2 B |
| 1Y Total Return |
-24.03%
Below Average |
| 1Y Volatility |
77.70%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Aphria Inc. produces and sells medical cannabis in Canada and internationall
Details
| Ticker | APHA |
| Name | Aphria |
| ISIN | CA03765K1049 |
| CUSIP | |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Producer |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 9/18/20
| Close Price | 4.68 |
| 52W Low/High | 2.13 / 6.16 |
| Market cap | 1.2 B |
| 1Y Total Return |
-24.03%
Below Average |
| 1Y Volatility |
77.70%
High Risk |
| Beta | 1.46 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -15.6% |
| Cash from Op. / Cur. Liabilities | -0.79 |
| Diluted Earnings / Share | -0.24 |
| ROE | - |
| ROIC | -3.7% |
| Price / Revenue | 3.1 |
| Price / Book | 0.9 |
| Price / CF | -12.5 |
| Current Ratio | 5.3 |
| Cur.Liabilities / Tot.Liabilities | 0.3 |
| Financial Leverage | 0.23 |
| in Mils USD |
rolling-year up to June
|
||||
|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | |
| Revenue |
394
|
177
|
29
|
15
|
|
| Gross Profit |
139
|
56
|
32
|
13
|
|
| R&D |
2
|
1
|
0
|
0
|
|
| EBITDA |
-4
|
1
|
33
|
5
|
|
| Operating Income |
-48
|
-108
|
-10
|
-1
|
|
| Net Income exc. Extra |
-
|
-
|
23
|
3
|
|
| per Share | |||||
| Diluted avg Shares |
258
|
243
|
166
|
111
|
|
| EPS exc. Extra |
-0.24
|
-0.05
|
0.14
|
0.03
|
|
| Dividend |
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
| Total Assets |
1,810
|
1,822
|
1,019
|
234
|
|
| Cash, Eq & Invt ShortTerm |
371
|
464
|
83
|
124
|
|
| Total Current Assets |
655
|
583
|
151
|
133
|
|
| Total Non-Current Assets |
1,156
|
1,239
|
868
|
101
|
|
| Intangibles |
711
|
792
|
581
|
2
|
|
| Total Liabilities |
478
|
529
|
109
|
31
|
|
| Total Current Liabilities |
123
|
103
|
34
|
8
|
|
| Long Term Debt |
355
|
425
|
75
|
24
|
|
| Shareholder equity |
1,313
|
1,272
|
902
|
203
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | |
| Cash from Operations |
-97
|
-41
|
-4
|
4
|
|
| Depreciation |
36
|
17
|
5
|
1
|
|
| Cash from Investing |
-68
|
-133
|
-171
|
-150
|
|
| Capex |
95
|
154
|
168
|
50
|
|
| Cash from Financing |
126
|
541
|
160
|
193
|
|
| Stock Issued |
76
|
189
|
158
|
169
|
|
| Debt (LT) Issued |
50
|
351
|
-6
|
24
|
|
| Free Cash Flow |
-223
|
-197
|
-142
|
-46
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | |
| Net Profit Margin |
-
|
-
|
79.8%
|
20.5%
|
|
| NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
| Current Ratio |
5.3
|
5.6
|
4.4
|
17.4
|
|
| Financial Leverage D/E |
0.23
|
0.29
|
0.03
|
0.12
|
|
| Return on Capital Avg |
-3.7%
|
-1.4%
|
-2.7%
|
1.9%
|
|
| Return on Shareholder Equity |
-
|
-
|
4.1%
|
1.5%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available